Статті в журналах з теми "DAB2IP"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "DAB2IP".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Liu, Liang, Cong Xu, Jer-Tsong Hsieh, Jianping Gong, and Daxing Xie. "DAB2IP in cancer." Oncotarget 7, no. 4 (December 8, 2015): 3766–76. http://dx.doi.org/10.18632/oncotarget.6501.
Повний текст джерелаSun, Liang, Yizhou Yao, Ting Lu, Zengfu Shang, Shenghua Zhan, Weiqiang Shi, Guofeng Pan, Xinguo Zhu, and Songbing He. "DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway." Gastroenterology Research and Practice 2018 (March 21, 2018): 1–10. http://dx.doi.org/10.1155/2018/2968252.
Повний текст джерелаYu, Lan, Yue Lang, Ching-Cheng Hsu, Wei-Min Chen, Jui-Chung Chiang, Jer-Tsong Hsieh, Michael D. Story, Zeng-Fu Shang, Benjamin P. C. Chen, and Debabrata Saha. "Mitotic phosphorylation of tumor suppressor DAB2IP maintains spindle assembly checkpoint and chromosomal stability through activating PLK1-Mps1 signal pathway and stabilizing mitotic checkpoint complex." Oncogene 41, no. 4 (November 13, 2021): 489–501. http://dx.doi.org/10.1038/s41388-021-02106-8.
Повний текст джерелаQiao, Shuhong, and Ramin Homayouni. "Dab2IP Regulates Neuronal Positioning, Rap1 Activity and Integrin Signaling in the Developing Cortex." Developmental Neuroscience 37, no. 2 (2015): 131–41. http://dx.doi.org/10.1159/000369092.
Повний текст джерелаDuan, Yifan, Xiaoyu Yin, Xiaorong Lai, Chao Liu, Wenjing Nie, Dongfeng Li, Zijun Xie, Zijun Li, and Fan Meng. "Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells." Technology in Cancer Research & Treatment 19 (January 1, 2020): 153303381989549. http://dx.doi.org/10.1177/1533033819895494.
Повний текст джерелаXu, He, Dapeng Wei, Jianxin Xue, and Lijuan Hu. "A Novel Monoclonal Antibody Against Human DAB2IP." Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 34, no. 4 (August 2015): 251–56. http://dx.doi.org/10.1089/mab.2015.0011.
Повний текст джерелаPerurena, Naiara, Natalie Pilla, Amy Schade, Marina Watanabe, Patrick Loi, Carrie L. Rodriguez, Alycia M. Gardner, and Karen Cichowski. "Abstract P1-13-06: Loss of emerging tumor and metastasis suppressor RasGAPs mediates therapeutic resistance in HER2+ breast cancer." Cancer Research 83, no. 5_Supplement (March 1, 2023): P1–13–06—P1–13–06. http://dx.doi.org/10.1158/1538-7445.sabcs22-p1-13-06.
Повний текст джерелаSu, Yintao, Fangyuan Shi, Zhanzhuang Zeng, Xiuling Wu, Yanhe Zhao, Lei Zhang, Zuofu Xie, and Yunkun Wu. "A Versatile Monoclonal Antibody Specific Against Human DAB2IP." Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 34, no. 4 (August 2015): 246–50. http://dx.doi.org/10.1089/mab.2015.0012.
Повний текст джерелаDai, Xiangpeng, Brian J. North, and Hiroyuki Inuzuka. "Negative regulation of DAB2IP by Akt and SCFFbw7 pathways." Oncotarget 5, no. 10 (May 1, 2014): 3307–15. http://dx.doi.org/10.18632/oncotarget.1939.
Повний текст джерелаLiu, S., N. Zhu, and H. Chen. "Expression patterns of human DAB2IP protein in fetal tissues." Biotechnic & Histochemistry 87, no. 5 (March 12, 2012): 350–59. http://dx.doi.org/10.3109/10520295.2012.664658.
Повний текст джерелаLi, Xiaoning, Xiangpeng Dai, Lixin Wan, Hiroyuki Inuzuka, Liankun Sun, and Brian J. North. "Smurf1 regulation of DAB2IP controls cell proliferation and migration." Oncotarget 7, no. 18 (March 27, 2016): 26057–69. http://dx.doi.org/10.18632/oncotarget.8424.
Повний текст джерелаLin, Chun-Jung, Andrew Dang, Elizabeth Hernandez, and Jer-Tsong Hsieh. "DAB2IP modulates primary cilia formation associated with renal tumorigenesis." Neoplasia 23, no. 1 (January 2021): 169–80. http://dx.doi.org/10.1016/j.neo.2020.12.002.
Повний текст джерелаHarrell Stewart, Desmond R., M. Lee Schmidt, Howard Donninger, and Geoffrey J. Clark. "The RASSF1A Tumor Suppressor Binds the RasGAP DAB2IP and Modulates RAS Activation in Lung Cancer." Cancers 12, no. 12 (December 17, 2020): 3807. http://dx.doi.org/10.3390/cancers12123807.
Повний текст джерелаWu, Kaijie, Daxing Xie, Yonglong Zou, Tingting Zhang, Rey-Chen Pong, Guanghua Xiao, Ladan Fazli, et al. "The Mechanism of DAB2IP in Chemoresistance of Prostate Cancer Cells." Clinical Cancer Research 19, no. 17 (July 9, 2013): 4740–49. http://dx.doi.org/10.1158/1078-0432.ccr-13-0954.
Повний текст джерелаXiao, Tian, Junchao Xue, Ming Shi, Chao Chen, Fei Luo, Hui Xu, Xiong Chen, et al. "Circ008913,viamiR-889 regulation of DAB2IP/ZEB1, is involved in the arsenite-induced acquisition of CSC-like properties by human keratinocytes in carcinogenesis." Metallomics 10, no. 9 (2018): 1328–38. http://dx.doi.org/10.1039/c8mt00207j.
Повний текст джерелаBellazzo, Arianna, Giulio Di Minin, and Licio Collavin. "Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer." Cell Death & Differentiation 24, no. 1 (November 18, 2016): 15–25. http://dx.doi.org/10.1038/cdd.2016.134.
Повний текст джерелаLee, Gum Hwa, Sun Hong Kim, Ramin Homayouni, and Gabriella D'Arcangelo. "Dab2ip Regulates Neuronal Migration and Neurite Outgrowth in the Developing Neocortex." PLoS ONE 7, no. 10 (October 4, 2012): e46592. http://dx.doi.org/10.1371/journal.pone.0046592.
Повний текст джерелаHarrison, Seamus C., Jackie A. Cooper, Kawah Li, Phillipa J. Talmud, Reecha Sofat, Jeffery W. Stephens, Anders Hamsten, et al. "Association of a sequence variant in DAB2IP with coronary heart disease." European Heart Journal 33, no. 7 (March 28, 2011): 881–88. http://dx.doi.org/10.1093/eurheartj/ehr075.
Повний текст джерелаDuan, Yi-Fan, Dong-Feng Li, Yan-Hui Liu, Ping Mei, Yu-Xuan Qin, Liang-Fang Li, Qiu-Xiong Lin, and Zi-Jun Li. "Decreased expression of DAB2IP in pancreatic cancer with wild-type KRAS." Hepatobiliary & Pancreatic Diseases International 12, no. 2 (April 2013): 204–9. http://dx.doi.org/10.1016/s1499-3872(13)60032-6.
Повний текст джерелаSon, Hyun Ji, Yun Sol Jo, Min Sung Kim, Nam Jin Yoo, and Sug Hyung Lee. "DAB2IP with tumor-inhibiting activities exhibits frameshift mutations in gastrointestinal cancers." Pathology - Research and Practice 214, no. 12 (December 2018): 2075–80. http://dx.doi.org/10.1016/j.prp.2018.10.005.
Повний текст джерелаXu, Yanting, Jiangtu He, Yue Wang, Xinyi Zhu, Qiuhui Pan, Qiuling Xie, and Fenyong Sun. "miR-889 promotes proliferation of esophageal squamous cell carcinomas through DAB2IP." FEBS Letters 589, no. 10 (April 1, 2015): 1127–35. http://dx.doi.org/10.1016/j.febslet.2015.03.027.
Повний текст джерелаZheng, Linfeng, Kaiyan Chen, Liang Zhu, Dan Su, and Guoping Cheng. "Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma." OncoTargets and Therapy Volume 10 (November 2017): 5719–26. http://dx.doi.org/10.2147/ott.s146952.
Повний текст джерелаBellazzo, Arianna, and Licio Collavin. "A mechanism for cell non-autonomous inactivation of the tumor suppressor DAB2IP." Oncoscience 5, no. 5-6 (June 29, 2018): 177–78. http://dx.doi.org/10.18632/oncoscience.441.
Повний текст джерелаZhou, Yunjiao, Zhenwei Yang, Hailin Zhang, Haiou Li, Meng Zhang, Haizhou Wang, Mengna Zhang, Peishan Qiu, Ruike Zhang, and Jing Liu. "DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation." Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868, no. 4 (April 2022): 166353. http://dx.doi.org/10.1016/j.bbadis.2022.166353.
Повний текст джерелаShan, Nan, Xiaoqiu Xiao, Ying Chen, Xin Luo, Nanlin Yin, Qinyin Deng, and Hongbo Qi. "Expression of DAB2IP in human trophoblast and its role in trophoblast invasion." Journal of Maternal-Fetal & Neonatal Medicine 29, no. 3 (January 21, 2015): 393–99. http://dx.doi.org/10.3109/14767058.2014.1001974.
Повний текст джерелаWu, K., J. Liu, S.-F. Tseng, C. Gore, Z. Ning, N. Sharifi, L. Fazli, et al. "The role of DAB2IP in androgen receptor activation during prostate cancer progression." Oncogene 33, no. 15 (April 22, 2013): 1954–63. http://dx.doi.org/10.1038/onc.2013.143.
Повний текст джерелаJacobs, Corbin, Vasu Tumati, Payal Kapur, Raquibul Hannan, Jer-Tsong Hsieh, Dong W. Kim, and Debabrata Saha. "Association of decreased tumor DAB2IP and high-risk prostate cancer-specific survival." Journal of Clinical Oncology 34, no. 15_suppl (May 20, 2016): e16553-e16553. http://dx.doi.org/10.1200/jco.2016.34.15_suppl.e16553.
Повний текст джерелаQiao, Shuhong, Sun-Hong Kim, Detlef Heck, Daniel Goldowitz, Mark S. LeDoux, and Ramin Homayouni. "Dab2IP GTPase Activating Protein Regulates Dendrite Development and Synapse Number in Cerebellum." PLoS ONE 8, no. 1 (January 9, 2013): e53635. http://dx.doi.org/10.1371/journal.pone.0053635.
Повний текст джерелаSalami, Farimah, Shuhong Qiao, and Ramin Homayouni. "Expression of mouse Dab2ip transcript variants and gene methylation during brain development." Gene 568, no. 1 (August 2015): 19–24. http://dx.doi.org/10.1016/j.gene.2015.05.012.
Повний текст джерелаWang, Guannan, Xu Wang, Meng Han, and Xiaoming Wang. "Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer." OncoTargets and Therapy Volume 14 (February 2021): 979–88. http://dx.doi.org/10.2147/ott.s289722.
Повний текст джерелаLuo, Xiaomin, Chunman Li, Ran Tan, Xiaohui Xu, William K. K. Wu, Ayano Satoh, Tuanlao Wang, and Sidney Yu. "A RasGAP, DAB2IP, regulates lipid droplet homeostasis by serving as GAP toward RAB40C." Oncotarget 8, no. 49 (August 3, 2017): 85415–27. http://dx.doi.org/10.18632/oncotarget.19960.
Повний текст джерелаZhang, Tingting, Yijun Shen, Ying Chen, Jer-Tsong Hsieh, and Zhaolu Kong. "The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect." International Journal of Radiation Biology 91, no. 4 (February 6, 2015): 368–78. http://dx.doi.org/10.3109/09553002.2015.1001531.
Повний текст джерелаFeng, Shengjie, Qingwen Huang, Jiao Deng, Weiyi Jia, Jianping Gong, Daxing Xie, Jie Shen, and Liang Liu. "DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer." Cancer Letters 532 (April 2022): 215588. http://dx.doi.org/10.1016/j.canlet.2022.215588.
Повний текст джерелаXie, D., C. Gore, J. Liu, R. C. Pong, R. Mason, G. Hao, M. Long, et al. "Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis." Proceedings of the National Academy of Sciences 107, no. 6 (January 13, 2010): 2485–90. http://dx.doi.org/10.1073/pnas.0908133107.
Повний текст джерелаXie, D., C. Gore, J. Zhou, R. C. Pong, H. Zhang, L. Yu, R. L. Vessella, W. Min, and J. T. Hsieh. "DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis." Proceedings of the National Academy of Sciences 106, no. 47 (November 10, 2009): 19878–83. http://dx.doi.org/10.1073/pnas.0908458106.
Повний текст джерелаHomayouni, Ramin, Susan Magdaleno, Lakhu Keshvara, Dennis S. Rice, and Tom Curran. "Interaction of Disabled-1 and the GTPase activating protein Dab2IP in mouse brain." Molecular Brain Research 115, no. 2 (July 2003): 121–29. http://dx.doi.org/10.1016/s0169-328x(03)00176-1.
Повний текст джерелаQiao, Shuhong, Farimah Salami, and Ramin Homayouni. "ISDN2014_0390: REMOVED: Dab2IP regulates neuronal migration and Rap1 activity in the developing cortex." International Journal of Developmental Neuroscience 47, Part_A (December 2015): 115. http://dx.doi.org/10.1016/j.ijdevneu.2015.04.310.
Повний текст джерелаHuang, Jun, Bin Wang, Ke Hui, Jin Zeng, Jinhai Fan, Xinyang Wang, Jer-Tsong Hsieh, Dalin He, and Kaijie Wu. "miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion." Oncology Reports 36, no. 3 (July 15, 2016): 1693–701. http://dx.doi.org/10.3892/or.2016.4940.
Повний текст джерелаZong, Xingyue, Weini Wang, Ali Ozes, Fang Fang, George E. Sandusky, and Kenneth P. Nephew. "EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells." Cancer Research 80, no. 20 (August 19, 2020): 4371–85. http://dx.doi.org/10.1158/0008-5472.can-20-0458.
Повний текст джерелаSamadaian, Niusha, Pouya Salehipour, Mohsen Ayati, Naser Rakhshani, Ali Najafi, Mandana Afsharpad, Fatemeh Yazarlou, and Mohammad Hossein Modarressi. "A potential clinical significance of DAB2IP and SPRY2 transcript variants in prostate cancer." Pathology - Research and Practice 214, no. 12 (December 2018): 2018–24. http://dx.doi.org/10.1016/j.prp.2018.09.019.
Повний текст джерелаPeng, Chih-Yu, Che-Yi Lin, Szu-Han Chen, Yi-Wen Liao, Cheng-Chia Yu, and Shiao-Pieng Lee. "microRNA-1266-5p directly targets DAB2IP to enhance oncogenicity and metastasis in oral cancer." Journal of Dental Sciences 17, no. 2 (April 2022): 718–24. http://dx.doi.org/10.1016/j.jds.2021.11.001.
Повний текст джерелаLEGAKI, EVANGELIA, CHRISTOS KLONARIS, DIMITRIOS ATHANASIADIS, NIKOLAOS PATELIS, ANNA SIOZIOU, THEODOROS LIAKAKOS, and MARIA GAZOULI. "DAB2IP Expression in Abdominal Aortic Aneurysm: EZH2 and mir-363-3p as Potential Mediators." In Vivo 33, no. 3 (2019): 737–42. http://dx.doi.org/10.21873/invivo.11533.
Повний текст джерелаLuo, Xiaomin, Chunman Li, Ran Tan, Xiaohui Xu, William K. K. Wu, Ayano Satoh, Tuanlao Wang, and Sidney Yu. "Correction: A RasGAP, DAB2IP, regulates lipid droplet homeostasis by serving as GAP toward RAB40C." Oncotarget 9, no. 17 (March 2, 2018): 14035. http://dx.doi.org/10.18632/oncotarget.24600.
Повний текст джерелаYun, E.-J., S. T. Baek, D. Xie, S.-F. Tseng, T. Dobin, E. Hernandez, J. Zhou, et al. "DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1." Oncogene 34, no. 21 (July 21, 2014): 2741–52. http://dx.doi.org/10.1038/onc.2014.215.
Повний текст джерелаValentino, Elena, Arianna Bellazzo, Giulio Di Minin, Daria Sicari, Mattia Apollonio, Giosuè Scognamiglio, Maurizio Di Bonito, Gerardo Botti, Giannino Del Sal, and Licio Collavin. "Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP." Proceedings of the National Academy of Sciences 114, no. 29 (June 30, 2017): 7623–28. http://dx.doi.org/10.1073/pnas.1700996114.
Повний текст джерелаZhang, Xiaojing, Ning Li, Xianzheng Li, Wei Zhao, Yudan Qiao, Li Liang, and Yanqing Ding. "Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma." Journal of Gastroenterology and Hepatology 27, no. 6 (May 24, 2012): 1117–25. http://dx.doi.org/10.1111/j.1440-1746.2011.07049.x.
Повний текст джерелаXie, Daxing, Jun Liu, Crystal Gore, Guiyang Hao, Michael Long, Xiankai Sun, and Jer-Tsong Hsieh. "THE IMPACT OF DAB2IP ON EPITHELIAL-MESENCHYMAL TRANSITION (EMT) LEADING TO PROSTATE CANCER METASTASIS." Journal of Urology 181, no. 4S (April 2009): 512. http://dx.doi.org/10.1016/s0022-5347(09)61446-4.
Повний текст джерелаLiu, Jing, Meng Zhang, Cong Xu, Haizhou Wang, Ya N. Peng, Chang Gao, Lan Liu, and Qiu Zhao. "Sa1198 - Mechanical Force Regulates Colorectal Tumorrepopulating Cells Self-Renewal Through Dab2Ip Mediated Nanog Expression." Gastroenterology 154, no. 6 (May 2018): S—275. http://dx.doi.org/10.1016/s0016-5085(18)31279-4.
Повний текст джерелаLIAO, HAIQIU, YANG XIAO, YINGBIN HU, YANGMING XIAO, ZHAOFA YIN, and LIANG LIU. "microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells." Oncology Letters 10, no. 4 (July 30, 2015): 2055–62. http://dx.doi.org/10.3892/ol.2015.3551.
Повний текст джерелаCao, Haoyuan, Jiandong Zhang, and Wei Wang. "DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma." Technology in Cancer Research & Treatment 19 (January 1, 2020): 153303382093668. http://dx.doi.org/10.1177/1533033820936682.
Повний текст джерела